The use of supernatants from neuraminidase and galactose oxidase (NAGO)-treated lymphocytes as a source of T cell growth factor
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 63 (3) , 309-319
- https://doi.org/10.1016/s0022-1759(83)80004-0
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Alloactivated long‐term cultured human T lymphocytes express both HLA‐DR and SB antigens but lack lymphocyte stimulation capacityEuropean Journal of Immunology, 1982
- Characterization of a soluble suppressor of human B cell immunoglobulin biosynthesis produced by a continuous human suppressor T cell line.The Journal of Experimental Medicine, 1981
- Mitogen-initiated synthesis and secretion of T cell growth factor(s) by a T-lymphoma cell line.The Journal of Experimental Medicine, 1980
- In vitro generation of K562 killers in human T-lymphocyte subsetsCellular Immunology, 1980
- Generation of a lymphocyte growth factor by treatment of human cells with neuraminidase and galactose oxidase.The Journal of Experimental Medicine, 1980
- Purification, Fractionation and Assay of Antibody‐Dependent Lymphocytic Effector Cells (K Cells) in Human BloodScandinavian Journal of Immunology, 1976
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976
- Long‐Term Maintenance In Vitro of Human T Cells by Repeated Exposure to the Same Stimulator CellsScandinavian Journal of Immunology, 1975
- Selective activation of mouse T and B lymphocytes by periodate, galactose oxidase and soybean agglutininEuropean Journal of Immunology, 1974
- Sensitization of Human Lymphocytes Against Autologous or Allogeneic Lymphoblastoid Cell Lines: Characteristics of the Reactive CellsScandinavian Journal of Immunology, 1974